These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36920504)

  • 21. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
    McMillin GA; Johnson-Davis K; Dasgupta A
    Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of electrochemiluminescence immunoassay and latex agglutination turbidimetric immunoassay for evaluation of everolimus blood concentrations in renal transplant patients.
    Akamine Y; Sato S; Kagaya H; Ohkubo T; Satoh S; Miura M
    J Clin Pharm Ther; 2018 Oct; 43(5):675-681. PubMed ID: 29679392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.
    Schniedewind B; Niederlechner S; Galinkin JL; Johnson-Davis KL; Christians U; Meyer EJ
    Ther Drug Monit; 2015 Jun; 37(3):296-303. PubMed ID: 25970506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood.
    Cangemi G; Barco S; Bonifazio P; Maffia A; Agazzi A; Melioli G
    Int J Immunopathol Pharmacol; 2013; 26(2):419-26. PubMed ID: 23755756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 4 Commercial Immunoassays Used in Measuring the Concentration of Tacrolimus in Blood and Their Cross-Reactivity to Its Metabolites.
    Shigematsu T; Suetsugu K; Yamamoto N; Tsuchiya Y; Masuda S
    Ther Drug Monit; 2020 Jun; 42(3):400-406. PubMed ID: 31568181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Everolimus TDM using Thermo Fisher QMS immunoassay on Indiko, Beckman DxC, AU680, and AU5800 analyzers.
    Wong SH; Johnson-Davis KL; Garrison K; Rankin JD; Muhammad CS
    Clin Biochem; 2017 May; 50(7-8):425-430. PubMed ID: 27988326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of sirolimus concentrations in human blood using an automated electrochemiluminescence immunoassay (ECLIA): a multicenter evaluation.
    Stove V; Ramos PA; Wallemacq P; Vogeser M; Schuetzenmeister A; Schmiedel C; Shipkova M
    Clin Chem Lab Med; 2018 Apr; 56(5):764-775. PubMed ID: 29206642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of whole-blood sirolimus concentrations measured by EMIT-based Siemens Viva-ProE® System and LC-MS/MS in Chinese transplant patients.
    Lin R; Cai Y; Huang Y; Li X; Chen Y; Chen B; Lai K; Wu J; Cheng Y; Liu M; Chen Y; Qiu H
    J Pharm Biomed Anal; 2024 Sep; 247():116271. PubMed ID: 38850850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer® qDBS device.
    Deprez S; Van Uytfanghe K; Stove CP
    Anal Chim Acta; 2023 Feb; 1242():340797. PubMed ID: 36657891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer.
    Willemsen AECAB; Knapen LM; de Beer YM; Brüggemann RJM; Croes S; van Herpen CML; van Erp NP
    Eur J Clin Pharmacol; 2018 Apr; 74(4):465-471. PubMed ID: 29222715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
    Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
    Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods.
    Sallustio BC; Noll BD; Morris RG
    Clin Biochem; 2011 Feb; 44(2-3):231-6. PubMed ID: 20970416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous Determination of Everolimus, Sirolimus, Tacrolimus, and Cyclosporine-A by Mass Spectrometry.
    Dinéia Perez J; Sanches Aragão D; Aparecida Ronchi F; Febba AC; Rosso CF; Tedesco-Silva Junior H; Medina de Abreu Pestana JO; Casarini DE
    Transplant Proc; 2020 Jun; 52(5):1402-1408. PubMed ID: 32220480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volumetric Absorptive Microsampling for the Therapeutic Drug Monitoring of Everolimus in Patients Who Have Undergone Liver Transplant.
    Yoo S; Kim G; Kim S; Ha J; Cho BS; Joo DJ; Lee JI
    Ther Drug Monit; 2023 Apr; 45(2):223-228. PubMed ID: 36127775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a Novel Immunoassay for Lacosamide Therapeutic Drug Monitoring: Comparison With a Liquid Chromatography-Mass Spectrometry Assay.
    DʼUrso A; Ricotta T; de Grazia U
    Ther Drug Monit; 2017 Dec; 39(6):663-668. PubMed ID: 29135908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
    Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
    Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].
    Chung JW; An D; Song J; Chung HJ; Park HI; Lee W; Chun S; Min WK
    Korean J Lab Med; 2009 Oct; 29(5):415-22. PubMed ID: 19893350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Latex-enhanced turbidimetric immunoassay for everolimus in whole blood using the Nanopia TDM everolimus assay with the JCA-BM6010 automatic analyzer.
    Mori K; Kimura S; Matsui M; Suehisa E; Hidaka Y; Fukushima N
    Ther Drug Monit; 2014 Oct; 36(5):677-80. PubMed ID: 25222856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
    Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
    Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.